test

Derek Gould

@Logos Global Management Lp

Latest period2024 - Q3ReportedManaged Assets$926.849MTotal holdings55
Assets growth rate-62.55%Assets growth rate (2-Q avg)18.89%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Logos Global Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Logos Global Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 926.849M in assets, with a quarterly growth rate of -62.55% and a 2-quarter average growth rate of 18.89%. The portfolio is managed by Derek Gould, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BCAXBicara Therapeutics Inc
Recent Activity
New Position
2.2%
$20.376M
800,000 shares@ $25.47 avg price
SRPTSarepta Therapeutics Inc
Recent Activity
Decreased -88.46%
2.03%
$18.733M
150,000 shares@ $124.89 avg price
ANNXAnnexon Inc
Recent Activity
Decreased -72.91%
1.67%
$15.392M
2.6M shares@ $5.92 avg price
TVTXTravere Therapeutics Inc
Recent Activity
New Position
1.67%
$15.389M
1.1M shares@ $13.99 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
Decreased -58.4%
1.37%
$12.642M
495,000 shares@ $25.54 avg price
BEAMBeam Therapeutics Inc
Recent Activity
New Position
1.33%
$12.25M
500,000 shares@ $24.5 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
New Position
1.3%
$12.011M
450,000 shares@ $26.69 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
New Position
1.23%
$11.315M
500,000 shares@ $22.63 avg price
YMABY-mabs Therapeutics Inc
Recent Activity
New Position
1.14%
$10.52M
800,000 shares@ $13.15 avg price
ARVNArvinas Inc
Recent Activity
New Position
1.07%
$9.852M
400,000 shares@ $24.63 avg price